Pediheart Podcast #144: Hydroxychloroquine To Prevent Recurrent Heart Block In The Offspring Of Anti-SSA/Ro-Positive Mothers episode artwork

EPISODE · Dec 18, 2020 · 41 MIN

Pediheart Podcast #144: Hydroxychloroquine To Prevent Recurrent Heart Block In The Offspring Of Anti-SSA/Ro-Positive Mothers

from Pediheart: Pediatric Cardiology Today · host Robert Pass

This week we review the topic of heart block in the newborn or fetus and review a novel prospective trial assessment of hydroxychloroquine to reduce recurrences of heart block in the offspring of Anti-SSA/Ro-positive mothers. We speak with Professor Jill Buyon and Professor Peter Izmirly, both of NYU Medical Center about a recent multi center trial assessing the impact of this agent for this purpose. How effective was this drug and what if any complications were encountered? What is next in the study of this topic? Drs. Buyon and Izmirly share many insights this week. doi: 10.1016/j.jacc.2020.05.045

Episode metadata supplied by the publisher feed · Published Dec 18, 2020

Embed this episode

Ready to play

Pediheart Podcast #144: Hydroxychloroquine To Prevent Recurrent Heart Block In The Offspring Of Anti-SSA/Ro-Positive Mothers

0:00 41:24

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Pediheart: Pediatric Cardiology Today?

This episode is 41 minutes long.

When was this Pediheart: Pediatric Cardiology Today episode published?

This episode was published on December 18, 2020.

Can I download this Pediheart: Pediatric Cardiology Today episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!